Indication
Pancreatic Metastases
2 clinical trials
2 products
3 drugs
Clinical trial
A Phase II Pilot Trial Of Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and the Addition Of Paricalcitol Upon Disease Progression in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma (NABPLAGEMD)Status: Completed, Estimated PCD: 2023-12-11
Product
ParicalcitolClinical trial
Phase IB/II Trial of High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have No Prior Therapy for Their Metastatic Pancreatic CancerStatus: Completed, Estimated PCD: 2021-09-14
Product
Ascorbic AcidDrug
AbraxaneDrug
CisplatinDrug
Gemcitabine